Topical Maintenance Treatments in Chronic Dermatitis

1. Yan F, Zhang J, Li X, Mo X, Liu J, Ye S, et al. Therapeutic Effects of Chinese Herbal Formula (PTQX) on NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions. Evid Based Complement Alternat Med. 2019;2019:1-13.10.1155/2019/1808419694831131949464Search in Google Scholar

2. Arellano FM, Wentworth CE, Arana A, Fernández C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol. 2007;127(4):808-816.10.1038/sj.jid.570062217096020Search in Google Scholar

3. Rotaru M, Ionescu A, Rotaru BI, Iancu GM. Etiopathogenic and therapeutic considerations in atopic dermatitis. Acta Medica Transilvanica. 2019;24(2):34-38.Search in Google Scholar

4. Mitchell AE. Bidirectional relationships between psychological health and dermatological conditions in children. Psychol Res Behav Manag. 2018;11:289-298.10.2147/PRBM.S117583607476230104911Search in Google Scholar

5. Sadr Mohammadi R, Bidaki R, Mirdrikvand F, Mostafavi Yazdi SN, Yazdian Anari P. Peganum Harmala (Aspand) Intoxication; a Case Report. Emerg (Tehran). 2016;4(2):106-107.Search in Google Scholar

6. Wollenberg A, Folster-Holst R, Saint Aroman M et al. Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients. JEADV. 2018;32 (Suppl. 1):1-15.10.1111/jdv.1484629533490Search in Google Scholar

7. Kang NJ, Han SC, Yoon SH, Yoon JY, Maeng YH, Kang HK, et al. Cinnamomum camphora Leaves Alleviate Allergic Skin Inflammatory Responses In Vitro and In Vivo. Toxicol Res. 2019;35(3):279-285.10.5487/TR.2019.35.3.279662944631341557Search in Google Scholar

8. Smeriglio A, Denaro M, Mastracci L, Grillo F, Cornara L, Shirooie S, et al. Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model. Daru. 2019;27(1):283-293.10.1007/s40199-019-00274-3659300131129807Search in Google Scholar

9. Theoharides TC, Stewart JM, Tsilioni I. Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion. Int J Immunopathol Pharmacol. 2017;30(2):146-151.10.1177/0394632017707610580679728480804Search in Google Scholar

10. Lee JH, Lee YJ, Lee JY, Park YM. Topical Application of Eupatilin Ameliorates Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice. Ann Dermatol. 2017;29(1):61-68.10.5021/ad.2017.29.1.61531852928223748Search in Google Scholar

11. Lee NR, Lee HJ, Yoon NY, Kim D, Jung M, Choi EH. Application of Topical Acids Improves Atopic Dermatitis in Murine Model by Enhancement of Skin Barrier Functions Regardless of the Origin of Acids. Ann Dermatol. 2016;28(6):690-696.10.5021/ad.2016.28.6.690512594927904267Search in Google Scholar

12. Aries MF, Hernandez-Pigeon H, Vaissière C, Delga H, Caruana A, Lévêque M, et al. Anti-inflammatory and immunomodulatory effects of Aquaphilus dolomiae extract on in vitro models. Clin Cosmet Investig Dermatol. 2016;9:421-434.10.2147/CCID.S113180510849327877060Search in Google Scholar

13. Rashmi S, Nahid A, Tariq M. H. Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. Life Sci. 2010;86(25-26):907-918.10.1016/j.lfs.2010.04.013314629420462508Search in Google Scholar

14. Kowalska M, Mendrycka M, Zbikowska A, Kowalska D. Assessment of a stable cosmetic preparation based on enzymatic intersterified fat, proposed in the prevention of atopic dermatitis. Acta Pol Pharm. 2017;74(2):465-476.Search in Google Scholar

15. Stein Gold LF, Spelman L, Spellman MC, Hughes MH, Zane LT. A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis. JDD. 2015;14(12):1394-1399Search in Google Scholar

16. Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman N, Mallbris L, et al. Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol. 2016;175(5):902-911.10.1111/bjd.1487127423107Search in Google Scholar

17. Bissonnette R, Pavel AB, Diaz A, Werth JL, Zang C, Vranic I, et al. Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial. J Allergy Clin Immunol. 2019;144:1274-89.10.1016/j.jaci.2019.06.04731419544Search in Google Scholar

18. Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494-503.10.1016/j.jaad.2016.05.04627417017Search in Google Scholar

19. Gueniche A, Knaudt B, Schuck E et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol. 2008;159:1357-1363.10.1111/j.1365-2133.2008.08836.x18795916Search in Google Scholar

20. Kim BS, Howell MD, Sun K, Papp K, Nasir A, Kuligowski ME, et al. Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream. J Allergy Clin Immunol. 2019;1-12.10.1016/j.jaci.2019.08.04231629805Search in Google Scholar

21. Awad N, Preuss CV. Halobetasol Cream. [Updated 2020 Feb 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available from:https://www.ncbi.nlm.nih.gov/books/NBK544234/Search in Google Scholar

22. Lee YW, Won CH, Jung K, Nam HJ, Choi G, Park YH, et al. Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial. Br J Dermatol. 2019;180(5):1030-1038.10.1111/bjd.17455685041930623408Search in Google Scholar

23. Nakai K, Kubota Y, Soma GI, Kohchi C. The Effect of Lipopolysaccharide-containing Moisturizing Cream on Skin Care in Patients With Mild Atopic Dermatitis. In Vivo. 2019;33(1):109-114.10.21873/invivo.11446636405030587610Search in Google Scholar